Telsey Advisory lowered the firm’s price target on Zevia (ZVIA) to $5 from $6 and keeps an Outperform rating on the shares. While the company reported mixed Q4 results, the firm notes Zevia is making progress on its turnaround visible from its 2026 sales growth guidance, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVIA:
- Zevia price target lowered to $1.75 from $2.90 at Morgan Stanley
- Zevia price target lowered to $3 from $3.50 at Goldman Sachs
- Zevia: Mixed Quarter, Cost Headwinds, and Strategy Refocus Support Balanced Risk-Reward and Hold Rating
- Zevia reports Q4 EPS (2c), consensus (3c)
- Zevia sees Q1 revenue $40M-$42M, consensus $40.5M